345 related articles for article (PubMed ID: 10490924)
21. Differential ability of D1 and D2 dopamine receptor agonists to induce and modulate expression and reinstatement of cocaine place preference in rats.
Graham DL; Hoppenot R; Hendryx A; Self DW
Psychopharmacology (Berl); 2007 Apr; 191(3):719-30. PubMed ID: 16835769
[TBL] [Abstract][Full Text] [Related]
22. Effects of dopamine D1-like and D2-like agonists in rats trained to discriminate cocaine from saline: influence of experimental history.
Caine SB; Negus SS; Mello NK; Bergman J
Exp Clin Psychopharmacol; 2000 Aug; 8(3):404-14. PubMed ID: 10975632
[TBL] [Abstract][Full Text] [Related]
23. Dopamine D1-like receptors agonist SKF 38393 increases cFOS expression in the paraventricular nucleus of the hypothalamus--impact of acute and chronic cocaine.
Chocyk A; Czyrak A; Wedzony K
J Physiol Pharmacol; 2008 Sep; 59(3):425-40. PubMed ID: 18953088
[TBL] [Abstract][Full Text] [Related]
24. Pretreatment with the dopamine agonist 7-OH-DPAT shifts the cocaine self-administration dose-effect function to the left under different schedules in the rat.
Caine SB; Koob GF
Behav Pharmacol; 1995 Jun; 6(4):333-347. PubMed ID: 11224342
[TBL] [Abstract][Full Text] [Related]
25. The GABAB agonist baclofen modifies cocaine self-administration in rats.
Shoaib M; Swanner LS; Beyer CE; Goldberg SR; Schindler CW
Behav Pharmacol; 1998 May; 9(3):195-206. PubMed ID: 9832934
[TBL] [Abstract][Full Text] [Related]
26. Synergistic elevations in nucleus accumbens extracellular dopamine concentrations during self-administration of cocaine/heroin combinations (Speedball) in rats.
Hemby SE; Co C; Dworkin SI; Smith JE
J Pharmacol Exp Ther; 1999 Jan; 288(1):274-80. PubMed ID: 9862781
[TBL] [Abstract][Full Text] [Related]
27. Long-lasting decreases in cocaine-reinforced behavior following treatment with the cholinesterase inhibitor tacrine in rats selectively bred for drug self-administration.
Grasing K; He S; Yang Y
Pharmacol Biochem Behav; 2009 Nov; 94(1):169-78. PubMed ID: 19698738
[TBL] [Abstract][Full Text] [Related]
28. The reinforcing effects of dopamine D1 receptor agonists in rhesus monkeys.
Weed MR; Woolverton WL
J Pharmacol Exp Ther; 1995 Dec; 275(3):1367-74. PubMed ID: 8531104
[TBL] [Abstract][Full Text] [Related]
29. Neurochemical and behavioral responses to cocaine in adult male rats with neonatal isolation experience.
Kosten TA; Zhang XY; Kehoe P
J Pharmacol Exp Ther; 2005 Aug; 314(2):661-7. PubMed ID: 15845857
[TBL] [Abstract][Full Text] [Related]
30. Effects of the competitive N-methyl-D-aspartate receptor antagonist, LY235959 [(-)-6-phosphonomethyl-deca-hydroisoquinoline-3-carboxylic acid], on responding for cocaine under both fixed and progressive ratio schedules of reinforcement.
Allen RM; Carelli RM; Dykstra LA; Suchey TL; Everett CV
J Pharmacol Exp Ther; 2005 Oct; 315(1):449-57. PubMed ID: 16024734
[TBL] [Abstract][Full Text] [Related]
31. Effects of intra-nucleus accumbens shell administration of dopamine agonists and antagonists on cocaine-taking and cocaine-seeking behaviors in the rat.
Bachtell RK; Whisler K; Karanian D; Self DW
Psychopharmacology (Berl); 2005 Nov; 183(1):41-53. PubMed ID: 16163523
[TBL] [Abstract][Full Text] [Related]
32. Antagonism of the discriminative stimulus effects of cocaine at two training doses by dopamine D2-like receptor antagonists.
Costanza RM; Barber DJ; Terry P
Psychopharmacology (Berl); 2001 Nov; 158(2):146-53. PubMed ID: 11702088
[TBL] [Abstract][Full Text] [Related]
33. Effects of N-methyl-D-aspartate antagonists in rats discriminating different doses of cocaine: comparison with direct and indirect dopamine agonists.
Kantak KM; Edwards MA; Spealman RD
J Pharmacol Exp Ther; 1995 Aug; 274(2):657-65. PubMed ID: 7636725
[TBL] [Abstract][Full Text] [Related]
34. Activation of dopamine D1 receptors in the medial prefrontal cortex produces bidirectional effects on cocaine-induced locomotor activity in rats: effects of repeated stress.
Sorg BA; Li N; Wu W; Bailie TM
Neuroscience; 2004; 127(1):187-96. PubMed ID: 15219681
[TBL] [Abstract][Full Text] [Related]
35. Dissociation of cocaine-antagonist properties and motoric effects of the D1 receptor partial agonists SKF 83959 and SKF 77434.
Platt DM; Rowlett JK; Spealman RD
J Pharmacol Exp Ther; 2000 Jun; 293(3):1017-26. PubMed ID: 10869406
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological characterization of the novel discriminative stimulus effects of a low dose of cocaine.
Terry P; Witkin JM; Katz JL
J Pharmacol Exp Ther; 1994 Sep; 270(3):1041-8. PubMed ID: 7932151
[TBL] [Abstract][Full Text] [Related]
37. Discriminative stimulus properties of cocaine in relation to dopamine D2 receptor function in rats.
Callahan PM; Cunningham KA
J Pharmacol Exp Ther; 1993 Aug; 266(2):585-92. PubMed ID: 8355192
[TBL] [Abstract][Full Text] [Related]
38. Dopamine D2/D3 receptors modulate cocaine's reinforcing and discriminative stimulus effects in rhesus monkeys.
Sinnott RS; Mach RH; Nader MA
Drug Alcohol Depend; 1999 Apr; 54(2):97-110. PubMed ID: 10217549
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the discriminative-stimulus effects of SKF 38393 with those of other dopamine receptor agonists.
Desai RI; Terry P; Katz JL
Behav Pharmacol; 2003 May; 14(3):223-8. PubMed ID: 12799524
[TBL] [Abstract][Full Text] [Related]
40. Characterization of dopamine D1 and D2 receptor function in socially housed cynomolgus monkeys self-administering cocaine.
Czoty PW; Morgan D; Shannon EE; Gage HD; Nader MA
Psychopharmacology (Berl); 2004 Jul; 174(3):381-8. PubMed ID: 14767632
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
